KALLO INC. (OTCMKTS:KALO) Files An 8-K Entry into a Material Definitive Agreement

KALLO INC. (OTCMKTS:KALO) Files An 8-K Entry into a Material Definitive Agreement

Story continues below

ITEM 1.01

ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On April 8, 2017, we entered into an agreement with FE Pharmacy
Inc., an Ontario corporation wherein in consideration of the
issuance by us of 475,000,000 post reverse-split restricted
shares of our common stock to FE Pharmacy, FE Pharmacy will pay
all of our outstanding indebtedness as of April 7, 2017. The
reverse stock split referred to herein is a contemplated 1 for
600 share reverse split of our common stock.
ITEM 3.02 UNREGISTERED SALE OF EQUITY SECURITIES
On April 8, 2017, we entered into an agreement with FE Pharmacy
Inc., an Ontario corporation wherein in consideration of the
issuance by us of 475,000,000 post reverse-split restricted
shares of our common stock to FE Pharmacy, FE Pharmacy will pay
all of our outstanding indebtedness as of April 7, 2017. The
reverse stock split referred to herein is a contemplated 1 for
600 share reverse split of our common stock.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
Exhibits
Document Description
10.1
Agreement with FE Pharmacy Inc. dated April 8, 2017


About KALLO INC. (OTCMKTS:KALO)

Kallo Inc., formerly Diamond Technologies Inc., is focused on developing medical information technology software. The Company focuses on the delivery and support of an end-to-end healthcare solution for developing countries and rural communities. Its healthcare solution, Kallo Integrated Delivery System (KIDS), consists of over three components: Care Platforms, Digital Technology, and Education and Training, which includes the education and training for various aspects of healthcare management, such as clinical, including clinical informatics, engineering including bio-medical, information and communications technology, and health administration. The Company has ownership rights of the products, which include EMR Integration Engine, Communicable and Infectious Disease Information Management System (C&ID-IMS) and Clinical-Care Globalization technology (CCG Technology) that are under development, and Mobile Clinic Telehealth System (M.C. Telehealth).

KALLO INC. (OTCMKTS:KALO) Recent Trading Information

KALLO INC. (OTCMKTS:KALO) closed its last trading session 00.00000 at 0.00010 with 96,121,115 shares trading hands.

An ad to help with our costs